The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some observations upon a new inhibitor of monoamine oxidase in brain tissue
Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,578
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,206
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
Langston, J. W., Irwin, I., Langston, E. B., & Forno, L. S. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90293-3 · Cited by 435
Brain monoamine oxidase A inhibition in cigarette smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14065 · Cited by 423
Smoking cessation and the course of major depression: A follow-up study
Glassman, A. H., Covey, L. S., Stetner, F., & Rivelli, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05064-9 · Cited by 370
Clinical Pharmacology of MAO Inhibitors: Safety and Future
Yamada, M. (2004) · NeuroToxicology · doi:10.1016/s0161-813x(03)00097-4 · Cited by 324
Inhibition of Monoamine Oxidase A by β-Carboline Derivatives
Kim, H., Sablin, S. O., & Ramsay, R. R. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9771 · Cited by 253
Monoamine oxidase and cigarette smoking
Fowler, J. S., Logan, J., Wang, G.-J., & Volkow, N. D. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(02)00109-2 · Cited by 251
Smoking and Parkinson’s and Alzheimer’s disease: review of the epidemiological studies
Fratiglioni, L., & Wang, H.-X. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00206-0 · Cited by 245
O'Carroll, A.-M., Fowler, C. J., Phillips, J. P., Tobbia, I., & Tipton, K. F. (1983) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00500765 · Cited by 230
The Metabolism of Tyramine by Monoamine Oxidase A/B Causes Oxidative Damage to Mitochondrial DNA
Hauptmann, N., Grimsby, J., Shih, J. C., & Cadenas, E. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0510 · Cited by 221
Kalgutkar, A. S., Dalvie, D. K., Castagnoli, & Taylor, T. J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx010073b · Cited by 209
The isolation of harmane and norharmane from tobacco and cigarette smoke
Poindexter, E. H., & Carpenter, R. D. (1962) · Phytochemistry · doi:10.1016/s0031-9422(00)82825-3 · Cited by 176
Youdim, M. (2004) · NeuroToxicology · doi:10.1016/s0161-813x(03)00103-7 · Cited by 160
Monoamine oxidase A and B activities in heavy smokers
Berlin, I., Saïd, S., Spreux‐Varoquaux, O., Olivares, R., Launay, J., & Puech, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00084-4 · Cited by 134
β-carboline binding to imidazoline receptors
Husbands, S. M., Glennon, R. A., Gorgerat, S., Gough, R., Tyacke, R. J., Crosby, J. C., Nutt, D., Lewis, J. W., & Hudson, A. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00123-5 · Cited by 126
Neuropharmacological Actions of Cigarette Smoke: Brain Monoamine Oxidase B (MAO B) Inhibition
Fowler, J. S., Volkow, N. D., Wang, G., Pappas, N. R., Logan, J., MacGregor, R. R., Alexoff, D. L., Wolf, A. P., Warner, D., Cilento, R., et al. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n01_03 · Cited by 124
Low platelet monoamine oxidase activity in cigarette smokers
Oreland, L., Fowler, C. J., & Schalling, D. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90706-2 · Cited by 124
Irreversible inhibition of monoamine oxidase by some components of cigarette smoke
Yu, P. H., & Boulton, A. A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90446-2 · Cited by 122
Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain
Matsubara, K., Collins, M. A., Akane, A., Ikebuchi, J., Neafsey, E. J., Kagawa, M., & Shiono, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)91221-d · Cited by 112
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase.
Yu, A., Idle, J. R., Herraiz, T., Kupfer, A., & Gonzalez, F. J. (2003) · PubMed · doi:10.1097/01.fpc.0000054094.48725.b7 · Cited by 111
Self-citationThe levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets
Rommelspacher, H., Meier-Henco, M., Smolka, M. N., & Kloft, C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01452-8 · Cited by 98
Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco Leaves
Khalil, A. A., Steyn, S., & Castagnoli, N. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990146f · Cited by 94
Low monoamine oxidase B in peripheral organs in smokers
Fowler, J. S., Logan, J., Wang, G., Volkow, N. D., Telang, F., Zhu, W., Franceschi, D., Pappas, N. R., Ferrieri, R. A., Shea, C. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1833106100 · Cited by 86
Harmane Induces Anxiolysis and Antidepressant‐Like Effects in Rats
Arıcıoğlu, F., & Altunbas, H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1304.024 · Cited by 84
Baum, S. S., Hill, R., & Rommelspacher, H. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00543-2 · Cited by 83
Identification and occurrence of the bioactive β-carbolines norharman and harman in coffee brews
Herraiz, T. (2002) · Food Additives & Contaminants · doi:10.1080/02652030210145892 · Cited by 81
Self-citationPlatelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms
Behm, F. M., Rose, J. E., Ramsey, C., & Ritchie, J. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110087277 · Cited by 72
Occurence and partition of the β-carboline norharman in rat organs
Fekkes, D., & Bode, W. T. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90689-z · Cited by 71
Clinical Pharmacology of Monoamine Oxidase Inhibitors
McDaniel, K. D. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198606000-00001 · Cited by 70
Adell, A., Biggs, T. A. G., & MYERS, R. D. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00043-3 · Cited by 70
Platelet monoamine oxidase: Low activity in cigarette smokers
Norman, T. R., Chamberlain, K. G., & French, M. A. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90079-5 · Cited by 69
Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking
Breyer-Pfaff, U., Wiatr, G., Stevens, I., Gaertner, H. J., Mundle, G., & Mann, K. F. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00112-9 · Cited by 67
Méndez‐Álvarez, E., Soto‐Otero, R., Sánchez‐Sellero, I., & López‐Rivadulla, M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00114-8 · Cited by 66
Castagnoli, K., & Murugesan, T. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00107-4 · Cited by 59
Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?
Tabakman, R., Lecht, S., & Lazarovici, P. (2003) · BioEssays · doi:10.1002/bies.10378 · Cited by 59
Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco
Castagnoli, K., Steyn, S. J., Petzer, J. P., der Schyf, C. J. V., & Castagnoli, N. J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000224v · Cited by 57
The impact of smoking and drinking on plasma levels of norharman
Spijkerman, R., van den Eijnden, R. J. J. M., van de Mheen, D., Bongers, I. M. B., & Fekkes, D. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00143-2 · Cited by 53
Hauptmann, N., & Shih, J. C. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01022-5 · Cited by 52
Carr, L. A., & Basham, J. K. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90455-k · Cited by 50
Endogenous β‐Carbolines as Clonidine‐Displacing Substances
ROBINSON, E., ANDERSON, N., CROSBY, J., Nutt, D., & Hudson, A. L. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1304.018 · Cited by 47
Adell, A., & MYERS, R. D. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90248-8 · Cited by 44
Monoamine Oxidase B Induces ERK-Dependent Cell Mitogenesis by Hydrogen Peroxide Generation
Vindis, C., Séguélas, M., Bianchi, P., Parini, A., & Cambon, C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2524 · Cited by 44
Berlin, I., Spreux‐Varoquaux, O., Saïd, S., & Launay, J. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)01338-0 · Cited by 33
Pawlik, M., & Rommelspacher, H. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90775-3 · Cited by 33
Ruiz‐Durántez, E., Ruíz-Ortega, J. Á., Pineda, J., & Ugedo, L. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02010-9 · Cited by 33
BIOGENIC AMINE ADDUCTS, MONOAMINE OXIDASE INHIBITORS, AND SMOKING
Boulton, A. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90308-x · Cited by 25
REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS IN RESISTANT MAJOR DEPRESSION
Nolen, W. A., Hoencamp, E., Bouvy, P. F., & Haffmans, P. M. J. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00225 · Cited by 21
Glassman, A. H., & Koob, G. F. (1996) · Nature · doi:10.1038/379677a0 · Cited by 21
Using monoamine oxidase type B inhibitors in Parkinson's disease
Ben‐Shlomo, Y., & Bhatia, K. (2004) · BMJ · doi:10.1136/bmj.329.7466.581 · Cited by 18
Smoking and Parkinson's disease
Honig, L. S., Gorell, J. M., Rybicki, B. A., Johnson, C. C., & Peterson, E. L. (1999) · Neurology · doi:10.1212/wnl.53.5.1158 · Cited by 11
Cited by
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1883 · Cited by 1,363
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.019 · Cited by 357
Neuroinflammation in psychiatric disorders: PET imaging and promising new targets
Meyer, J. H., Cervenka, S., Kim, M.-J., Kreisl, W. C., Henter, I. D., & Innis, R. B. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30255-8 · Cited by 270
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01652.x · Cited by 244
Smoking and suicide: A brief overview
Hughes, J. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.003 · Cited by 236
Metadata
- Authors
- Herraiz, T., & Chaparro, C.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 326
- Issue
- 2
- Pages
- 378-386
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2060712684
- Cited by
- 258
- References
- 52
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.